BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 36900148)

  • 1. Clinical Characteristics and Current Status of Treatment for Recurrent Bladder Cancer after Surgeries on Upper Tract Urothelial Carcinoma.
    Hu X; Xue Y; Zhu G
    Diagnostics (Basel); 2023 Mar; 13(5):. PubMed ID: 36900148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinicopathological characteristics of muscle-invasive bladder recurrence in upper tract urothelial carcinoma.
    Shigeta K; Matsumoto K; Ogihara K; Murakami T; Anno T; Umeda K; Izawa M; Baba Y; Sanjo T; Shojo K; Tanaka N; Takeda T; Kosaka T; Mizuno R; Mikami S; Kikuchi E; Oya M
    Cancer Sci; 2021 Mar; 112(3):1084-1094. PubMed ID: 33368857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of subsequent non-muscle-invasive bladder cancer treated with intravesical Bacillus Calmette-Guérin after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
    Miyake M; Tatsumi Y; Matsumoto H; Nagao K; Matsuyama H; Inamoto T; Azuma H; Yasumoto H; Shiina H; Fujimoto K;
    BJU Int; 2018 May; 121(5):764-773. PubMed ID: 29281857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bladder Recurrence Following Upper Tract Surgery for Urothelial Carcinoma: A Contemporary Review of Risk Factors and Management Strategies.
    Mertens LS; Sharma V; Matin SF; Boorjian SA; Houston Thompson R; van Rhijn BWG; Masson-Lecomte A
    Eur Urol Open Sci; 2023 Mar; 49():60-66. PubMed ID: 36793750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors for Unfavorable Pathological Types of Intravesical Recurrence in Patients With Upper Urinary Tract Urothelial Carcinoma Following Radical Nephroureterectomy.
    Zhu J; Zhang X; Yu W; Li X; He Z; Zhou L; Zhang Z; Xiong G
    Front Oncol; 2022; 12():834692. PubMed ID: 35494036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors for Intravesical Recurrence after Minimally Invasive Nephroureterectomy for Upper Tract Urothelial Cancer (ROBUUST Collaboration).
    Katims AB; Say R; Derweesh I; Uzzo R; Minervini A; Wu Z; Abdollah F; Sundaram C; Ferro M; Rha K; Mottrie A; Rosiello G; Simone G; Eun DD; Reese A; Kidd LC; Porter J; Bhattu AS; Gonzalgo ML; Margulis V; Marcus J; Danno A; Meagher M; Tellini R; Mari A; Veccia A; Ghoreifi A; Autorino R; Djaladat H; Mehrazin R
    J Urol; 2021 Sep; 206(3):568-576. PubMed ID: 33881931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and oncological outcome for intravesical recurrence in organ-confined upper urinary tract urothelial carcinoma patients after radical nephroureterectomy: A propensity score-matched case control study.
    Jiang Y; Yao Z; Zhu X; Wu B; Bai S
    Int J Surg; 2020 Apr; 76():28-34. PubMed ID: 32081714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma: a meta-analysis.
    Yuan H; Chen X; Liu L; Yang L; Pu C; Li J; Bai Y; Han P; Wei Q
    Urol Oncol; 2014 Oct; 32(7):989-1002. PubMed ID: 25082191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factor analysis of intravesical recurrence after retroperitoneoscopic nephroureterectomy for upper tract urothelial carcinoma.
    Yanagi M; Hamasaki T; Akatsuka J; Endo Y; Takeda H; Kondo Y
    BMC Urol; 2021 Dec; 21(1):167. PubMed ID: 34856960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiling the Biological Characteristics and Transitions through Upper Tract Tumor Origin, Bladder Recurrence, and Muscle-Invasive Bladder Progression in Upper Tract Urothelial Carcinoma.
    Shigeta K; Matsumoto K; Tanaka N; Mikami S; Kosaka T; Yasumizu Y; Takeda T; Mizuno R; Kikuchi E; Oya M
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative Monocyte-to-lymphocyte Ratio Predicts for Intravesical Recurrence in Patients With Urothelial Carcinoma of the Upper Urinary Tract After Radical Nephroureterectomy Without a History of Bladder Cancer.
    Liu J; Wu P; Lai S; Song X; Fu C; Wang X; Liu S; Hou H; Liu M; Wang J
    Clin Genitourin Cancer; 2021 Jun; 19(3):e156-e165. PubMed ID: 33121908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic Review.
    Peyronnet B; Seisen T; Dominguez-Escrig JL; Bruins HM; Yuan CY; Lam T; Maclennan S; N'dow J; Babjuk M; Comperat E; Zigeuner R; Sylvester RJ; Burger M; Mostafid H; van Rhijn BWG; Gontero P; Palou J; Shariat SF; Roupret M
    Eur Urol Focus; 2019 Mar; 5(2):205-223. PubMed ID: 29154042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of upper tract urothelial carcinoma on response to BCG in patients with non-muscle-invasive bladder cancer.
    Bree KK; Hensley PJ; Brooks NA; Matulay J; Li R; Nogueras Gonzalez GM; Navai N; Grossman HB; Matin SF; Dinney CPN; Kamat AM
    BJU Int; 2021 Nov; 128(5):568-574. PubMed ID: 33484074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Systematic Review and Meta-analysis of Clinicopathologic Factors Linked to Intravesical Recurrence After Radical Nephroureterectomy to Treat Upper Tract Urothelial Carcinoma.
    Seisen T; Granger B; Colin P; Léon P; Utard G; Renard-Penna R; Compérat E; Mozer P; Cussenot O; Shariat SF; Rouprêt M
    Eur Urol; 2015 Jun; 67(6):1122-1133. PubMed ID: 25488681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of previous, simultaneous or intravesical recurrence bladder cancer on prognosis of upper tract urothelial carcinoma after nephroureterectomy: a large population-based study.
    Zeng S; Ying Y; Yu X; Wang L; Zhang Z; Xu C
    Transl Androl Urol; 2021 Dec; 10(12):4365-4375. PubMed ID: 35070818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative Pyuria Predicts for Intravesical Recurrence in Patients With Urothelial Carcinoma of the Upper Urinary Tract After Radical Nephroureterectomy Without a History of Bladder Cancer.
    Sato G; Yoshida T; Yanishi M; Saito R; Murota T; Kawa G; Kinoshita H; Matsuda T
    Clin Genitourin Cancer; 2020 Apr; 18(2):e167-e173. PubMed ID: 31635939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of Intravesical Recurrence After Radical Nephroureterectomy and Prognosis in Patients with Upper Tract Urothelial Carcinoma.
    Li YR; Yu KJ; Chang YH; Lin PH; Shao IH; Kan HC; Chu YC; Chuang CK; Pang ST; Liu CY
    Cancer Manag Res; 2020; 12():7439-7450. PubMed ID: 32884355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors and prognosis of intravesical recurrence after surgical management of upper tract urothelial carcinoma: A 30-year single centre experience.
    Elawdy MM; Osman Y; Taha DE; Zahran MH; El-Halwagy S; Garba ME; Harraz AM
    Arab J Urol; 2017 Sep; 15(3):216-222. PubMed ID: 29071155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bladder mapping of tumour recurrence after radical nephroureterectomy for upper tract urothelial carcinoma and its influence on oncological outcomes.
    Belhadj Y; Grande P; Seisen T; Gobert A; Gomez FD; Cussenot O; Roupret M
    BJU Int; 2019 Apr; 123(4):618-623. PubMed ID: 30548115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.